Insulet Corp. (PODD)
139.98
-5.36
(-3.69%)
USD |
NASDAQ |
Nov 18, 16:00
139.94
-0.04
(-0.03%)
After-Hours: 20:00
Insulet Enterprise Value : 10.09B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 10.09B |
| November 17, 2026 | 10.46B |
| November 16, 2026 | 10.46B |
| November 13, 2026 | 10.95B |
| November 12, 2026 | 10.73B |
| November 11, 2026 | 10.78B |
| November 10, 2026 | 10.65B |
| November 09, 2026 | 10.77B |
| November 06, 2026 | 10.54B |
| November 05, 2026 | 11.21B |
| November 04, 2026 | 11.82B |
| November 03, 2026 | 11.12B |
| November 02, 2026 | 11.03B |
| October 30, 2026 | 10.76B |
| October 29, 2026 | 10.96B |
| October 28, 2026 | 10.71B |
| October 27, 2026 | 10.77B |
| October 26, 2026 | 10.73B |
| October 23, 2026 | 10.71B |
| October 22, 2026 | 10.65B |
| October 21, 2026 | 10.22B |
| October 20, 2026 | 10.27B |
| October 19, 2026 | 10.23B |
| October 16, 2026 | 10.17B |
| October 15, 2026 | 10.00B |
| Date | Value |
|---|---|
| October 14, 2026 | 9.668B |
| October 13, 2026 | 9.959B |
| October 12, 2026 | 10.08B |
| October 09, 2026 | 9.762B |
| October 08, 2026 | 9.705B |
| October 07, 2026 | 9.698B |
| October 06, 2026 | 9.724B |
| October 05, 2026 | 9.785B |
| October 02, 2026 | 9.513B |
| October 01, 2026 | 9.450B |
| September 30, 2026 | 9.428B |
| September 29, 2026 | 9.626B |
| September 28, 2026 | 9.645B |
| September 25, 2026 | 9.854B |
| September 24, 2026 | 9.830B |
| September 23, 2026 | 9.879B |
| September 22, 2026 | 10.08B |
| September 21, 2026 | 10.16B |
| September 18, 2026 | 10.16B |
| September 17, 2026 | 10.23B |
| September 16, 2026 | 10.16B |
| September 15, 2026 | 10.07B |
| September 14, 2026 | 9.970B |
| September 11, 2026 | 9.565B |
| September 10, 2026 | 9.754B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 74.78B |
| Abbott Laboratories | 208.41B |
| TransMedics Group, Inc. | 3.722B |
| The Cooper Cos., Inc. | 13.94B |
| Stryker Corp. | 133.28B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 141.10M |
| Revenue (Quarterly) | 842.00M |
| Total Expenses (Quarterly) | 700.90M |
| EPS Diluted (Quarterly) | 2.030 |
| Gross Profit Margin (Quarterly) | 75.51% |
| Profit Margin (Quarterly) | 16.76% |
| Earnings Yield | 4.17% |
| Operating Earnings Yield | 6.00% |
| Normalized Earnings Yield | 4.166 |